专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP4448042A2 WEIGHT-BASED SYSTEMS FOR USE IN EXTRACORPOREAL BLOOD TREATMENT 失效
公开(公告)号：EP4448042A2
公开(公告)日：2024-10-23
申请号：EP22839169.4
申请日：2022-12-14
申请人： BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE SA
发明人： JANSSON, Olof , PETTERSSON, Michael , HERTZ, Thomas , FORS, Jonas , BORGQVIST, Per-Olof
IPC分类号： A61M1/16
CPC分类号： A61M2205/339320130101 , A61M1/1613 , A61M1/1643 , A61M1/1656

2. 发明公开

EP4360667A1 EXTRACORPOREAL BLOOD TREATMENT APPARATUS 审中-公开
公开(公告)号：EP4360667A1
公开(公告)日：2024-05-01
申请号：EP22203338.3
申请日：2022-10-24
申请人： Gambro Lundia AB
发明人： POUCHOULIN, Dominique
IPC分类号： A61M1/34 , A61M1/36
CPC分类号： A61M2205/1820130101 , A61M1/3672 , A61M1/3434 , A61M1/3458 , A61M1/361 , A61M1/1643
摘要： An extracorporeal blood treatment apparatus 1 has a filtration unit 2, a blood circuit 6, and a main infusion line 9 connected to a blood withdrawal line 6a to infuse a solution into blood. A main infusion pump 11 causes the infusion solution I to flow from an infusion fluid source 10 to the blood withdrawal line, and an inactivated condition, wherein the main infusion pump 11 is inactive; a concentrate sensor 12 is placed on the blood withdrawal line between an injection point 9a and the filtration unit 2 for monitoring the concentration of a substance. A control unit 13, in the first operating condition, activates the main infusion pump 11 and acquires the signal from the concentrate sensor 12 to determine the concentration of the substance into blood infused with the infusion solution, and, in the second operating condition, inactivates the main infusion pump 11 and acquires the signal to determine the concentration of the substance when no infusion solution I is infused into the blood.

3. 发明公开

EP3144021A4 BLOOD PURIFICATION DEVICE 有权
公开(公告)号：EP3144021A4
公开(公告)日：2018-01-17
申请号：EP15792192
申请日：2015-05-13
申请人： NIKKISO CO LTD
发明人： MOCHIZUKI HIROAKI
IPC分类号： A61M1/14 , A61M1/16 , A61M5/14 , A61M5/168
CPC分类号： A61M1/367 , A61M1/14 , A61M1/1643 , A61M5/14 , A61M5/1417 , A61M5/16845 , A61M2205/18 , A61M2205/276 , A61M2205/3393 , A61M2209/082 , F16B45/02
摘要： The present invention provides a blood purification apparatus in which inadvertent replacement of a container bag attached to a hanger portion can be avoided. Provided is a blood purification apparatus including a holding device (2) capable of holding a container bag that contains a liquid for blood purification treatment, such as dialysate, substitution fluid, or anticoagulant, the blood purification apparatus being capable of performing blood purification treatment using the liquid in the container bag. The holding device (2) includes a hanger portion (2b) including an attachment portion (2c) to which the container bag can be attached, and movable between a use position in which the container bag is used and a replacement position in which the container bag is replaced, a measuring device (g) capable of measuring the weight of the container bag held by the hanger portion (2b), and a restricting device (6) that restricts attachment and detachment of the container bag to and from the attachment portion (2c) when the hanger portion (2b) is in the use position.

4. 发明授权

EP2670453B1 VERFAHREN UND VORRICHTUNG ZUR STEUERUNG EINER EXTRAKORPORALEN BLUTBEHANDLUNGSVORRICHTUNG 有权
标题翻译：控制外部血液处理装置的方法和装置
公开(公告)号：EP2670453B1
公开(公告)日：2017-12-13
申请号：EP12704668.8
申请日：2012-01-24
申请人： Fresenius Medical Care Deutschland GmbH
发明人： BREUEL, Lars , LINDNER, Thomas , BEDEN, Josef , HERKLOTZ, Martin , VERCH, Georg
IPC分类号： A61M1/16 , A61M1/34
CPC分类号： A61M1/16 , A61M1/1605 , A61M1/1643 , A61M1/342 , A61M1/3451 , A61M2205/3365 , A61M2205/3393 , Y10T137/86131

5. 发明授权

EP2019296B1 WEIGHT SENSOR AND BALANCE CONTROLLER 有权
标题翻译： GEWICHTSSENSOR UND BALANCESTEUERUNG
公开(公告)号：EP2019296B1
公开(公告)日：2017-01-18
申请号：EP07741511.5
申请日：2007-04-12
申请人： JMS Co., Ltd.
发明人： FUJII, Junya , KAMITO, Shogo , ENDO, Toshiyuki , SANSHO, Youichi
IPC分类号： G01G3/14 , A61M1/14 , A61M1/34 , G01G17/04 , G01G21/16
CPC分类号： G01G17/04 , A61M1/1613 , A61M1/1643 , A61M1/3417 , A61M1/3437 , A61M1/3441 , A61M1/3451 , Y10S128/13

6. 发明公开

EP3015123A1 Acute renal replacement therapy apparatus 有权
标题翻译： Akute Nierenersatztherapievorrichtung
公开(公告)号：EP3015123A1
公开(公告)日：2016-05-04
申请号：EP14190925.9
申请日：2014-10-29
申请人： B. Braun Avitum AG
发明人： István, Golarits , Botond, Tényi
IPC分类号： A61M1/34 , A61M1/16
CPC分类号： A61M1/3451 , A61M1/16 , A61M1/1615 , A61M1/1643 , A61M1/1647 , A61M1/34 , A61M1/3403 , A61M1/341 , A61M1/342 , A61M1/3441 , A61M1/3607 , A61M1/3663 , A61M2205/3331 , A61M2205/3334 , A61M2205/3379 , A61M2205/3393 , A61M2205/50
摘要： An acute renal replacement therapy apparatus comprises at least two feedback control means (110, 120), each including an estimated volume calculation means (112, 122) arranged to calculate an estimated volume based on a set flow, a comparing means (114, 124) arranged to compare the estimated volume with a measured volume, a volume deviation determining means (114, 124) arranged to determine a volume deviation based on the result of the comparison, a correction calculation means (116, 126) arranged to calculate a correction amount based on the determined volume deviation, a flow control generation means (116, 126) arranged to generate a controlled flow control signal based on the calculated correction amount and the set flow, and a feedback control output means (118, 128) arranged to output the controlled flow control signal to a pump individually associated with each feedback control means and forwarding fluid from a fluid source and/or pulling fluid into a fluid sink; and a flow correction distribution means (200) including an input means (210) arranged to input correction required signals calculated by and output from the correction calculation means in each of the at least two feedback control means, a limited correction signal calculation means (230) arranged to calculate a limited correction signal for each of the input correction required signals, and an output means arranged to output each calculated limited correction signal to the feedback control means from which its underlying correction required signal has been received.
摘要翻译：一种急性肾替代治疗装置包括至少两个反馈控制装置（110,120），每个反馈控制装置包括被布置为基于设定流量计算估计体积的估计体积计算装置（112,122），比较装置），布置成将所估计的体积与测量的体积进行比较;体积偏差确定装置（114,124），被布置为基于比较结果确定体积偏差;校正计算装置（116,126），被布置为计算校正基于所确定的体积偏差量的流量控制生成装置，被配置为基于所计算的校正量和设定流量生成受控流量控制信号的流量控制生成装置，以及反馈控制输出装置，将受控流量控制信号输出到与每个反馈控制装置单独关联的泵并将流体从流体源和/或将流体引入流体槽中; 以及流量校正分配装置（200），其包括输入装置（210），输入装置（210）被配置为输入由所述至少两个反馈控制装置中的每个反馈控制装置中的校正计算装置计算出的校正所需信号和从所述校正计算装置输出的校正所需信号; ），其被布置为针对每个输入校正所需信号计算有限校正信号;以及输出装置，被布置为将每个计算的限制校正信号输出到已经从其接收到其底层校正所需信号的反馈控制装置。

7. 发明授权

EP0607301B2 HEMOFILTRATION SYSTEM 有权转让
标题翻译： HÄMOFILTRATIONSSYSTEM
公开(公告)号：EP0607301B2
公开(公告)日：2004-12-08
申请号：EP92921805.5
申请日：1992-10-06
申请人： CHILDREN'S HOSPITAL MEDICAL CENTER
发明人： KITAEVICH, Yuli , HEMASILPIN, Nat , MARCHEVSKY, J., Gabriel , BISSLER, John, J. , BENZING, George, III , McENERY, Paul, T.
IPC分类号： A61M1/16
CPC分类号： A61M1/16 , A61M1/1643 , A61M1/34 , A61M1/341 , A61M1/3427 , A61M1/3451 , A61M1/3607 , A61M2205/15 , A61M2205/3331 , A61M2205/3334 , A61M2205/3344 , A61M2205/3368 , A61M2205/3393 , A61M2205/50 , Y10S210/929

8. 发明授权

EP0739234B1 HEMOFILTRATION AND PLASMAFILTRATION DEVICE 失效
标题翻译： VORRICHTUNG ZURHÄMOFILTRATIONUND PLASMAFILTRATION
公开(公告)号：EP0739234B1
公开(公告)日：2003-07-02
申请号：EP95908480.7
申请日：1995-01-11
申请人： HEMOCLEANSE, INC.
发明人： ASH, Stephen, R.
IPC分类号： B01D61/00 , B01D63/00 , B01D63/02 , B01D65/00 , B01D65/02 , B01D65/08 , A61M1/34
CPC分类号： B01D63/16 , A61M1/10 , A61M1/1005 , A61M1/1006 , A61M1/1062 , A61M1/1086 , A61M1/1627 , A61M1/1643 , A61M1/1649 , A61M1/1692 , A61M1/1696 , A61M1/26 , A61M1/267 , A61M1/30 , A61M1/304 , A61M1/308 , A61M1/3417 , A61M1/3427 , A61M1/3431 , A61M1/3458 , A61M1/3472 , A61M1/3475 , A61M1/3493 , A61M2205/12 , A61M2205/7563 , B01D61/00 , B01D61/145 , B01D61/243 , B01D61/58 , B01D65/08 , B01D2321/2066 , B01D2321/2083
摘要： Devices and methods for providing extracorporeal treatment of blood for effective plasmafiltration or hemofiltration are disclosed. The device incorporates a hollow fiber membrane device (HFD) connected in series with a parallel plate dialyzer (PPD). Sorbent suspension from a sorbent bag (101) first passes through the sorbent inlet (102) of the PPD, exits through sorbent outlet (103), is drawn into accumulator reservoir (104), is expelled from accumulator reservoir (104) and passes through check valve (105) in response to alternating positive pressure and negative pressure applied to the accumulator reservoir (104). The sorbent suspension then passes into HFD inlet (106) and through the outer chamber of the HFD, thus agitating and mixing the sorbent suspension into contact with exterior surfaces of the hollow fibers (107) in the HFD. Sorbent suspension exits the HFD from outlet (108) and passes through blood leak detector (109) and back into the sorbent bag (101).
摘要翻译：公开了提供用于血液或其它流体的体外治疗以用于单独或与透析组合的有效等离子体过滤或血液滤过的优选装置和方法。

9. 发明授权

EP0714312B1 APPARATUS FOR PURIFIED PULSE PERITONEAL DIALYSIS 失效
标题翻译： GERÄTFÜRDIE GEPULSTE PERITONEALDIALYSE MIT REGENERIERTEM DIALYSAT
公开(公告)号：EP0714312B1
公开(公告)日：2001-08-29
申请号：EP95922909.7
申请日：1995-05-24
申请人： BAXTER INTERNATIONAL INC.
发明人： KESHAVIAH, Prakash, R. , EMERSON, Paul, F. , RUAN, Jian
IPC分类号： A61M1/28
CPC分类号： A61M1/28 , A61M1/1611 , A61M1/1643 , A61M1/1696 , A61M1/281 , A61M2205/3393 , Y10S210/929

10. 发明公开

EP0739234A4 HEMOFILTRATION AND PLASMAFILTRATION DEVICES AND METHODS 失效
标题翻译：装置和血液滤过和血浆过滤方法
公开(公告)号：EP0739234A4
公开(公告)日：1999-03-03
申请号：EP95908480
申请日：1995-01-11
申请人： HEMOCLEANSE INC
发明人： ASH STEPHEN R
IPC分类号： A61M1/14 , A61M1/10 , A61M1/16 , A61M1/26 , A61M1/30 , A61M1/34 , B01D61/00 , B01D61/14 , B01D61/24 , B01D61/26 , B01D61/28 , B01D61/30 , B01D61/58 , B01D63/02 , B01D63/16 , B01D65/08 , B01D63/00 , B01D65/00 , B01D65/02
CPC分类号： B01D63/16 , A61M1/10 , A61M1/1005 , A61M1/1006 , A61M1/1062 , A61M1/1086 , A61M1/1627 , A61M1/1643 , A61M1/1649 , A61M1/1692 , A61M1/1696 , A61M1/26 , A61M1/267 , A61M1/30 , A61M1/304 , A61M1/308 , A61M1/3417 , A61M1/3427 , A61M1/3431 , A61M1/3458 , A61M1/3472 , A61M1/3475 , A61M1/3493 , A61M2205/12 , A61M2205/7563 , B01D61/00 , B01D61/145 , B01D61/243 , B01D61/58 , B01D65/08 , B01D2321/2066 , B01D2321/2083
摘要： Devices and methods for providing extracorporeal treatment of blood for effective plasmafiltration or hemofiltration are disclosed. The device incorporates a hollow fiber membrane device (HFD) connected in series with a parallel plate dialyzer (PPD). Sorbent suspension from a sorbent bag (101) first passes through the sorbent inlet (102) of the PPD, exits through sorbent outlet (103), is drawn into accumulator reservoir (104), is expelled from accumulator reservoir (104) and passes through check valve (105) in response to alternating positive pressure and negative pressure applied to the accumulator reservoir (104). The sorbent suspension then passes into HFD inlet (106) and through the outer chamber of the HFD, thus agitating and mixing the sorbent suspension into contact with exterior surfaces of the hollow fibers (107) in the HFD. Sorbent suspension exits the HFD from outlet (108) and passes through blood leak detector (109) and back into the sorbent bag (101).

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式